Alendronate was approved by the FDA in 1995. The FDA clearance of Fosamax® to treat osteoporosis is based on efficacy data from five clinical trials involving 1,827 postmenopausal women with osteoporosis in 16 countries who were followed for at least two years.

Please visit the official site of the FDA for further information.

 

Why is this medication prescribed?

Other uses for this medicine

Dosage and using this medicine

What special precautions should I follow?

What should I do if I forget a dose?

What side effects can this medication cause?

What storage conditions are needed for this medicine?

In case of an emergency/overdose